within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03G_GonadotropinsAndOtherOvulationStimulants.G03GA07_LutropinAlfa;

model LutropinAlfa
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 6.777777777777777e-08,
    adminDuration = 600,
    adminMass = 75 / 1000000,
    adminCount = 1,
    Vd = 0.0106,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>LutropinAlfa</td></tr><tr><td>ATC code:</td><td>G03GA07</td></tr><td>route:</td><td>subcutaneous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>75</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>10.6</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.244</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Lutropin alfa is a recombinant human luteinizing hormone (LH) used in combination with follicle stimulating hormone (FSH) for the stimulation of follicular development in women with severe LH and FSH deficiency. It is approved for therapeutic use in assisted reproductive technologies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult women with hypogonadotropic hypogonadism receiving subcutaneous administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G03GA07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end LutropinAlfa;
